Evidence map›Paper›PMID 39905191›Full record

ArticleScientific reports2025

A novel aggregated coefficient ranking based feature selection strategy for enhancing the diagnosis of breast cancer classification using machine learning.

E Sreehari, L D Dhinesh Babu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

E SreehariSchool of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
L D Dhinesh BabuSchool of Computer Science Engineering and Information Systems, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India. lddhineshbabu@vit.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Effective Breast cancer (BC) analysis is crucial for early prognosis, controlling cancer recurrence, timely medical intervention, and determining appropriate treatment procedures. Additionally, it plays a significant role in optimizing mortality rates among women with breast cancer and increasing the average lifespan of patients. This can be achieved by performing effective critical feature analysis of the BC by picking superlative features through significant ranking-based Feature Selection (FS). Various authors have developed strategies relying on single FS, but this approach may not yield excellent results and could lead to various consequences, including time and storage complexity issues, inaccurate results, poor decision-making, and difficult interpretation of models. Therefore, critical data analysis can facilitate the development of a robust ranking methodology for effective feature selection. To solve these problems, this paper suggests a new method called Aggregated Coefficient Ranking-based Feature Selection (ACRFS), which is based on tri chracteristic behavioral criteria. This strategy aims to significantly improve the ranking for an effective Attribute Subset Selection (ASSS). The proposed method utilized computational problem solvers such as chi-square, mutual information, correlation, and rank-dense methods. The work implemented the introduced methodology using Wisconsin-based breast cancer data and applied the Synthetic Minority Oversampling Technique (SMOTE) to the obtained data subset. Later, we employed models such as decision trees, support vector machines, k-nearest neighbors, random forests, stochastic gradient descent, and Gaussian naive bayes to determine the type of cancer. The classification metrics such as accuracy, precision, recall, F1 score, kappa score, and Matthews coefficient were utilized to evaluate the effectiveness of the suggested ACRFS approach. The proposed method has demonstrated superior outcomes with fewer features and a minimal time complexity.

Indexed as

Breast NeoplasmsMachine LearningAlgorithmsFemaleHumansPrognosis

Identifiers

PMID39905191
PMCPMC11794878

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.